Pei‐Ju Lien

529 total citations
33 papers, 367 citations indexed

About

Pei‐Ju Lien is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Pei‐Ju Lien has authored 33 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Pei‐Ju Lien's work include HER2/EGFR in Cancer Research (10 papers), Advanced Breast Cancer Therapies (6 papers) and Ovarian function and disorders (6 papers). Pei‐Ju Lien is often cited by papers focused on HER2/EGFR in Cancer Research (10 papers), Advanced Breast Cancer Therapies (6 papers) and Ovarian function and disorders (6 papers). Pei‐Ju Lien collaborates with scholars based in Taiwan and United States. Pei‐Ju Lien's co-authors include Sandra C. Souza, Ling‐Ming Tseng, Yi‐Fang Tsai, Yueching Wong, Chun‐Yu Liu, Chih‐Yi Hsu, Sheng‐Miauh Huang, Ta‐Chung Chao, Yuling Wang and Jen‐Hwey Chiu and has published in prestigious journals such as Diabetes, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Pei‐Ju Lien

31 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pei‐Ju Lien Taiwan 9 158 91 81 61 51 33 367
Uzay Görmüş Türkiye 16 235 1.5× 33 0.4× 80 1.0× 75 1.2× 68 1.3× 53 591
Samantha Greenberg United States 11 75 0.5× 41 0.5× 47 0.6× 69 1.1× 49 1.0× 49 432
Mei‐Leng Cheong Taiwan 13 191 1.2× 52 0.6× 15 0.2× 45 0.7× 49 1.0× 31 518
Wei Zou China 11 225 1.4× 32 0.4× 136 1.7× 52 0.9× 48 0.9× 28 580
Crystal D. Lin United States 9 150 0.9× 94 1.0× 110 1.4× 93 1.5× 52 1.0× 11 432
Joyce Huang United States 10 110 0.7× 64 0.7× 66 0.8× 63 1.0× 22 0.4× 23 308
Federico Centeno-Cruz Mexico 13 261 1.7× 63 0.7× 47 0.6× 35 0.6× 33 0.6× 38 447
Nanik Ram Pakistan 9 73 0.5× 30 0.3× 17 0.2× 32 0.5× 21 0.4× 39 322
Yinyun Ni China 11 243 1.5× 44 0.5× 143 1.8× 143 2.3× 72 1.4× 22 646

Countries citing papers authored by Pei‐Ju Lien

Since Specialization
Citations

This map shows the geographic impact of Pei‐Ju Lien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei‐Ju Lien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei‐Ju Lien more than expected).

Fields of papers citing papers by Pei‐Ju Lien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei‐Ju Lien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei‐Ju Lien. The network helps show where Pei‐Ju Lien may publish in the future.

Co-authorship network of co-authors of Pei‐Ju Lien

This figure shows the co-authorship network connecting the top 25 collaborators of Pei‐Ju Lien. A scholar is included among the top collaborators of Pei‐Ju Lien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei‐Ju Lien. Pei‐Ju Lien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Sheng‐Miauh, Ling‐Ming Tseng, Chi‐Cheng Huang, et al.. (2025). The development and validation testing of a comprehensive frailty assessment in women with breast cancer. BMC Women s Health. 25(1). 46–46. 1 indexed citations
2.
Cho, Rou‐Ling, Yu‐Lueng Shih, Pei‐Ju Lien, et al.. (2025). Nitroxoline upregulates low-density lipoprotein receptors expression, enhances lipid metabolism, and reduces hepatic steatosis and atherosclerosis in Apoe−/− mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(8). 168016–168016.
3.
Tsai, Yi-Fang, et al.. (2024). Real-world experience with CDK4/6 inhibitors in hormone receptor-positive metastatic and recurrent breast cancer: findings from an Asian population. Clinical and Experimental Medicine. 24(1). 185–185. 7 indexed citations
4.
Tsai, Yi‐Fang, Chi‐Cheng Huang, Chih‐Yi Hsu, et al.. (2024). Genomic Alterations of Tumors in HER2-Low Breast Cancers. International Journal of Molecular Sciences. 25(2). 1318–1318. 5 indexed citations
5.
Tsai, Yi‐Fang, et al.. (2023). Clinical characteristics and treatment outcomes of invasive ductal and lobular carcinoma: analyses of 54,832 taiwan cancer registry index cases. Breast Cancer Research and Treatment. 201(3). 547–560. 2 indexed citations
6.
Tsai, Yi‐Fang, Pei‐Ju Lien, Chun‐Yu Liu, et al.. (2023). Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan. Breast Cancer. 31(2). 217–227.
7.
Huang, Chi‐Cheng, Yi‐Fang Tsai, Chunyu Liu, et al.. (2023). Concordance of Targeted Sequencing from Circulating Tumor DNA and Paired Tumor Tissue for Early Breast Cancer. Cancers. 15(18). 4475–4475. 3 indexed citations
8.
Tsai, Yi‐Fang, Chun‐Yu Liu, Chih‐Yi Hsu, et al.. (2023). Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study. Breast Cancer Research. 25(1). 152–152. 2 indexed citations
9.
Tseng, Ling‐Ming, Chi‐Cheng Huang, Yi‐Fang Tsai, et al.. (2023). Correlation of an immune-related 8-gene panel with pathologic response to neoadjuvant chemotherapy in patients with primary breast cancers. Translational Oncology. 38. 101782–101782. 2 indexed citations
10.
Huang, Chi‐Cheng, Yi‐Fang Tsai, Chun‐Yu Liu, et al.. (2022). Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers. Annals of Surgical Oncology. 29(6). 3578–3590. 8 indexed citations
11.
Huang, Sheng‐Miauh, et al.. (2022). Developing a web-based oncofertility tool for reproductive-age women with breast cancer based on social support framework. Supportive Care in Cancer. 30(7). 6195–6204. 6 indexed citations
12.
Huang, Sheng‐Miauh, Ling‐Ming Tseng, & Pei‐Ju Lien. (2022). Effects of naturalistic decision-making model-based oncofertility care education for nurses and patients with breast cancer: a cluster randomized controlled trial. Supportive Care in Cancer. 30(10). 8313–8322. 2 indexed citations
13.
Huang, Chi‐Cheng, Yi‐Fang Tsai, Chunyu Liu, et al.. (2021). Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses. BMC Cancer. 21(1). 199–199. 13 indexed citations
14.
Huang, Yu-Hsiang, Pei‐Yi Chu, Ji‐Lin Chen, et al.. (2021). Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer. Scientific Reports. 11(1). 12171–12171. 20 indexed citations
15.
Tseng, Ling‐Ming, et al.. (2021). Developing a Web-Based Shared Decision-Making Tool for Fertility Preservation Among Reproductive-Age Women With Breast Cancer: An Action Research Approach. Journal of Medical Internet Research. 23(3). e24926–e24926. 10 indexed citations
16.
Tsai, Yi‐Fang, Chi‐Cheng Huang, Pei‐Ju Lien, et al.. (2021). Clinical outcomes and metastatic behavior between de novo versus recurrent HER2-positive metastatic breast cancer: A 17-year single-institution cohort study at Taipei Veterans General Hospital. Journal of the Chinese Medical Association. 85(1). 88–94. 4 indexed citations
17.
Liu, Chunyu, Chi‐Cheng Huang, Yi‐Fang Tsai, et al.. (2021). VGH-TAYLOR: Comprehensive Precision Medicine Study Protocol on the Heterogeneity of Taiwanese Breast Cancer Patients. Future Oncology. 17(31). 4057–4069. 8 indexed citations
18.
Huang, Sheng‐Miauh, et al.. (2019). Oncofertility to Evidence‐Based Practice: Changes in Fertility Intention and Symptom Burden in Reproductive‐Age Women With Breast Cancer. Worldviews on Evidence-Based Nursing. 16(5). 381–388. 8 indexed citations
19.
Chen, Po‐Ming, Pei‐Yi Chu, Shiao-Lin Tung, et al.. (2017). Overexpression of phosphoprotein phosphatase 2A predicts worse prognosis in patients with breast cancer: a 15-year follow-up. Human Pathology. 66. 93–100. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026